Krebs Stephanie 4
4 · Sensei Biotherapeutics, Inc. · Filed Nov 2, 2023
Insider Transaction Report
Form 4
Krebs Stephanie
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-01+125,000→ 125,000 totalExercise: $0.82Exp: 2033-10-31→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest and become exercisable as to 25% of the shares underlying the option on November 1, 2024, and the remaining 75% of the shares underlying the Option shall vest and become exercisable in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.